Review
The inhibitory glycine receptor: prospects for a therapeutic orphan?
Affiliations
- PMID: 10197046
Item in Clipboard
Review
The inhibitory glycine receptor: prospects for a therapeutic orphan?
Curr Pharm Des.
1998 Aug.
Abstract
The inhibitory glycine receptor is a member of the ligand-gated ion channel superfamily. It mediates inhibitory synaptic transmission in mammalian spinal cord and brainstem. Structure and function of the receptor, as well as its chromosomal localization and genetic structure, have been extensively studied. While hereditary and acquired receptor dysfunctions can be identified, selective and specific modulation of receptor function is still lacking. The preponderance of current literature regarding the inhibitory glycine receptor raises the prospect that adequate methods for the treatment of glycine receptor-mediated disorders might be developed.
Similar articles
-
The glycine receptor.Pharmacol Ther. 1997;73(2):121-46. doi: 10.1016/s0163-7258(96)00163-5. Pharmacol Ther. 1997. PMID: 9131721 Review.
-
The inhibitory glycine receptor-simple views of a complicated channel.Chembiochem. 2002 Nov 4;3(11):1042-52. doi: 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7. Chembiochem. 2002. PMID: 12404628 Review.
-
Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation.Curr Opin Neurobiol. 1997 Jun;7(3):358-67. doi: 10.1016/s0959-4388(97)80063-3. Curr Opin Neurobiol. 1997. PMID: 9232798 Review.
-
The inhibitory glycine receptor: architecture, synaptic localization and molecular pathology of a postsynaptic ion-channel complex.Curr Opin Neurobiol. 1995 Jun;5(3):318-23. doi: 10.1016/0959-4388(95)80044-1. Curr Opin Neurobiol. 1995. PMID: 7580154 Review.
-
Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses?Trends Pharmacol Sci. 2002 Nov;23(11):519-27. doi: 10.1016/s0165-6147(02)02138-7. Trends Pharmacol Sci. 2002. PMID: 12413807 Review.
Cited by
-
Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating.J Neurosci. 1999 Feb 1;19(3):869-77. doi: 10.1523/JNEUROSCI.19-03-00869.1999. J Neurosci. 1999. PMID: 9920650 Free PMC article.
-
Activation of human alpha1 and alpha2 homomeric glycine receptors by taurine and GABA.J Physiol. 2001 Sep 15;535(Pt 3):741-55. doi: 10.1111/j.1469-7793.2001.t01-1-00741.x. J Physiol. 2001. PMID: 11559772 Free PMC article.
-
Glycine receptor mouse mutants: model systems for human hyperekplexia.Br J Pharmacol. 2013 Nov;170(5):933-52. doi: 10.1111/bph.12335. Br J Pharmacol. 2013. PMID: 23941355 Free PMC article. Review.
-
In vivo protection against strychnine toxicity in mice by the glycine receptor agonist ivermectin.Biomed Res Int. 2014;2014:640790. doi: 10.1155/2014/640790. Epub 2014 Sep 15. Biomed Res Int. 2014. PMID: 25317421 Free PMC article.
-
Investigation of the alpha(1)-glycine receptor channel-opening kinetics in the submillisecond time domain.Biophys J. 1999 Aug;77(2):727-38. doi: 10.1016/S0006-3495(99)76927-4. Biophys J. 1999. PMID: 10423421 Free PMC article.